What Public Health England and the NHS Say About Vaping
PHE and NHS
on Vape
~95% less harmful foundation since 2015. NHS Stop Smoking Services include vape. For smokers yes. Non-smokers no. Here is the full UK institutional position.
Both support vape as harm reduction for smokers. PHE (now OHID) published landmark 2015 review estimating vape around 95 per cent less harmful than smoking. Subsequent evidence reviews maintained this position. NHS Stop Smoking Services actively include vape alongside NRT as cessation aid. NHS Better Health programme provides vape guidance for smokers wanting to quit. NHS website explicitly discusses vape as cessation aid. Consistent nuance throughout: vape is recommended for smokers as harm reduction, NOT recommended for non-smokers or minors. Full cessation of all nicotine remains preferred long-term goal. Position stable across decade plus. Appropriate caveats maintained about youth uptake, long-term uncertainty plus specific vulnerable groups. UK institutional consensus is among most supportive globally based on careful evidence evaluation.
Where UK institutions
stand on vape
Three facts covering the landmark foundation document, the NHS services inclusion plus the consistency across a decade.
PHE foundation
Public Health England commissioned review that estimated vape around 95% less harmful than smoking.
Active inclusion
Vape included alongside NRT as cessation option in NHS services nationally.
Position stable
Core UK harm reduction position maintained through PHE, OHID, NHS plus successive governments.
~95% foundation since 2015. NHS services include vape. Position stable.
Both Public Health England (now Office for Health Improvement and Disparities, OHID) plus the NHS support vape as harm reduction for smokers. PHE published landmark 2015 review estimating vape around 95 per cent less harmful than smoking. Subsequent evidence reviews have maintained this position. NHS Stop Smoking Services actively include vape as cessation aid. NHS Better Health programme provides vape guidance for smokers wanting to quit. Consistent nuance throughout: vape is recommended for smokers as harm reduction, NOT recommended for non-smokers or minors. Full cessation remains preferred long-term goal. Here is the institutional position, landmark documents plus how guidance has evolved. For the wider medical position see our doctors guide. This article is general consumer information, not medical advice.
Public Health England 2015: the landmark review
The foundational document for UK vape policy:
Background.
- Public Health England commissioned independent expert review.
- Emerging vape market raised regulatory questions.
- Review assessed available evidence on harm.
- Published August 2015.
Key findings.
- Vape around 95 per cent less harmful than smoking.
- Based on comprehensive evidence evaluation.
- Considered chemistry, absorption, exposure.
- Accounted for dependence and behavioural factors.
The 95 per cent figure.
- Became defining UK position on vape.
- Reflects order of magnitude difference not precise measurement.
- Has been internationally debated.
- Remains central to UK harm reduction framing.
Other findings.
- Vape use among smokers plausibly contributing to record quit rates.
- Not a gateway to smoking.
- Some media coverage was misleading.
- Harm reduction potential significant.
Impact.
- Shaped UK government vape policy.
- Influenced NHS position.
- Shaped medical professional guidance.
- Challenged international precautionary approaches.
Subsequent PHE evidence reviews
PHE published regular evidence reviews maintaining plus refining the position:
Annual reviews 2018-2021.
- Continued evidence accumulation.
- Updated harm reduction position.
- Monitoring of emerging concerns.
- Youth vape uptake increasingly noted.
Key updates over time.
- Confirmation vape helps smoking cessation.
- No clear link to serious diseases in users at that time.
- Vape-related hospitalisations (US EVALI) linked to illicit THC cartridges not regulated nicotine vape.
- Need for continued regulation plus youth protection emphasised.
Diacetyl ban (2016).
- UK TPD implementation included diacetyl ban.
- Reflected PHE plus other expert concerns about popcorn lung.
- Continued UK harm reduction approach with appropriate regulation.
Transition to OHID (2021)
Public Health England was abolished in 2021 with functions distributed:
Office for Health Improvement and Disparities (OHID).
- Successor body for much of PHE health improvement work.
- Continues vape evidence reviews.
- Maintains harm reduction position.
- Part of Department of Health and Social Care.
Continuity of position.
- Core PHE harm reduction stance maintained.
- Evidence review framework continues.
- No reversal of vape-for-smokers guidance.
- Ongoing updates as evidence develops.
Recent OHID reviews.
- Continued support for vape as cessation aid.
- Updated guidance on specific products.
- Contributed to disposable vape ban policy.
- Youth protection emphasis increased.
NHS position and practice
NHS implements UK vape policy in clinical and public health practice:
NHS Stop Smoking Services.
- Free structured cessation support available nationally.
- Vape included as cessation option alongside NRT.
- Trained stop smoking advisors deliver behavioural support.
- Access through GP referral or self-referral.
- Local councils commission services.
NHS Better Health.
- NHS plus government public health programme.
- Quit Smoking specific campaign.
- Vape included in quit smoking messaging.
- Public website at better-health.nhs.uk.
- App-based support including vape guidance.
NHS website content.
- NHS.uk explicitly discusses vape as smoking cessation aid.
- “Using e-cigarettes to stop smoking” guidance page.
- Public-facing accessible information.
- Regularly updated.
GP practice.
- Most UK GPs follow NHS guidance.
- May suggest vape for smokers unable to quit with NRT alone.
- Open non-judgmental conversations about vape use.
- Referral to Stop Smoking Services.
Hospital settings.
- Some hospitals include vape in cessation pathways.
- Pre-surgery cessation support may include vape.
- Mental health settings often include vape given high smoking rates.
Specific NHS messaging
Common themes in NHS public-facing communications:
Key messages for smokers.
- Switching to vape can help you quit smoking.
- Vape is substantially less harmful than smoking.
- Full cessation of all nicotine eventually best.
- NHS Stop Smoking Services offer free support.
- Vape plus behavioural support most effective.
Key messages for non-smokers.
- Vape is not recommended for non-smokers.
- No health benefit from starting vape.
- Dependence risk without compensating advantage.
- Not a wellness product.
Key messages for under-18s.
- Vape is not for minors.
- UK law restricts sale to 18+.
- Developmental concerns with nicotine use.
- Stronger lifetime dependence forms.
Key messages for pregnancy.
- Pregnant women should stop all nicotine where possible.
- NRT via midwife may be option for pregnant smokers unable to quit.
- Vape preferable to continued smoking if cessation impossible.
- Personalised midwife or GP advice essential.
How UK position compares internationally
UK is among most supportive globally:
UK: strongly supportive.
- Consumer product framework.
- NHS includes vape in cessation services.
- 95 per cent less harmful foundation.
- Adult access with regulation.
World Health Organization: cautious.
- Precautionary principle emphasis.
- Youth uptake concerns globally.
- Recommends restrictive regulation.
- Less supportive framing than UK.
Australia: medicalised.
- Prescription-only model for nicotine vape.
- Different approach from UK consumer model.
- Results mixed in early implementation.
United States: mixed.
- FDA regulatory framework.
- Product authorisations case-by-case.
- More youth-uptake-focused than UK.
EU: similar to UK.
- TPD framework that UK used plus retained.
- Variation between countries.
- Generally consumer product model.
Canada, New Zealand: similar to UK.
- Harm reduction position.
- Regulated consumer product.
- Cessation support includes vape.
Why UK position has remained consistent
Several factors support continued UK harm reduction position:
Evidence base.
- Cochrane Review 2024 confirmed effectiveness for cessation.
- Ongoing UK studies support position.
- No major vape-specific disease patterns emerging.
- Mechanism-based reasoning remains sound.
Institutional continuity.
- NHS, OHID, RCP all aligned.
- Successive governments have maintained position.
- Chief Medical Officers have endorsed.
- Independent expert reviews continue.
Public health history.
- UK has strong harm reduction tradition in other areas.
- Pragmatic evidence-based approach.
- Not ideologically opposed to nicotine in principle.
- Focused on smoking harm elimination.
Results.
- UK smoking rates have fallen with vape availability.
- Quit success rates higher with vape available.
- No major harm wave emerging.
- Position producing intended outcomes.
What PHE and NHS have been cautious about
Appropriate concerns maintained alongside supportive position:
- Youth uptake: major concern driving disposable ban plus marketing restrictions.
- Long-term effects: acknowledged uncertainty, ongoing monitoring.
- Non-smoker initiation: clearly not recommended.
- Product quality: TPD regulation plus compliance essential.
- Dependence: real concern even in smoking-cessation context.
- Pregnancy: extra caution appropriate.
- Specific products: disposable concerns addressed via ban.
Practical implications
For smokers:
- UK NHS position supports your switching decision.
- NHS Stop Smoking Services available including vape.
- GP can discuss vape cessation options.
- Evidence base supports effectiveness.
For current vapers:
- NHS non-judgmental position supports continued use.
- Step-down toward cessation encouraged over time.
- GP conversations welcome.
For non-smokers:
- NHS clearly advises against starting vape.
- Position consistent for decade plus.
For parents and carers:
- NHS clearly supports youth protection.
- Vape not appropriate for minors.
- UK 18+ law enforced.
Practical approach
- UK NHS plus PHE/OHID consistently supportive for smokers.
- 95 per cent less harmful foundation stable since 2015.
- NHS Stop Smoking Services actively include vape.
- Core nuance maintained: smokers yes, non-smokers no.
- Youth protection strengthened over time.
- Full cessation remains preferred long-term.
For smokers acting on UK NHS recommendations, our nicotine salts collection features UK TPD-compliant products across every legal strength from 20mg down to 3mg supporting effective switching plus eventual cessation.
How PHE and NHS position
has developed
UK institutional position on vape has developed plus remained consistent since 2015. Key milestones plus continuing evolution across a decade.
PHE landmark
Public Health England commissioned review estimated vape ~95% less harmful than smoking. Foundation of UK position.
Annual reviews
PHE published ongoing evidence reviews. Diacetyl banned 2016. Harm reduction position confirmed. Youth concerns emerging.
PHE to OHID
Public Health England replaced by Office for Health Improvement and Disparities. UK position continued unchanged.
Cochrane + Bill
Cochrane Review 2024 confirmed effectiveness vs NRT. Tobacco and Vapes Bill addressing youth protection. Position remains.
What PHE and NHS
have said consistently
~95% less harmful foundation
PHE 2015 landmark estimate. Shaped UK policy for decade. Supported by subsequent evidence.
NHS Stop Smoking Services include vape
Free structured support including vape alongside NRT. Available nationally. 2-3x success rates.
Consistent nuance maintained
For smokers yes. Non-smokers no. Minors no. Clear position for a decade plus.
Youth protection strengthening
Increasingly emphasised. Tobacco and Vapes Bill. Disposable ban. Advertising restrictions.
Shop the nicotine salts range
Our nicotine salts collection features UK TPD-compliant products across every legal strength from 20mg down to 3mg. For smokers acting on NHS harm reduction guidance. Free next-day delivery on orders over £20.
What aligns with NHS
guidance vs misinterprets
Specific approaches align with the consistent UK institutional position. Others misinterpret or misapply the guidance. Here is the side by side.
Aligned with NHS
- ✓For smokers: using NHS Stop Smoking Services with vape option official support structure.
- ✓Consulting GP about vape as cessation aid UK medical position supports this conversation.
- ✓UK TPD-compliant products from reputable retailers regulatory framework applies.
- ✓Following NHS age plus pregnancy guidance protects vulnerable groups.
- ✓Step-down toward full cessation long-term NHS preferred long-term outcome.
- ✓Staying informed via nhs.uk plus gov.uk official sources for current guidance.
Misinterprets
- ✗Non-smokers starting vape citing NHS support NHS explicitly NOT supporting this.
- ✗Providing vape to minors undermines UK youth protection framework.
- ✗Hiding vape use from GP UK medical position is supportive not judgmental.
- ✗Non-compliant products bypassing UK regulation safety testing not applied.
- ✗Assuming UK position applies globally international variation exists.
- ✗Pregnancy vape use without NHS midwife guidance specific assessment needed.
For the wider view on vape, NHS plus UK institutional positions, our full health hub covers every major question UK readers ask.
Back to the Prefilled Pod Systems guide
This article is one chapter inside our complete Prefilled Pod Systems knowledge base. Head back to the hub for the full index covering refilling, safety, longevity plus regulation.
More on UK medical position
For the broader UK medical consensus beyond just PHE and NHS including RCP and Cochrane, our piece on what doctors say about vaping as a smoking alternative covers that picture. For the direct vape vs smoking comparison backed by this position, is vaping better than smoking walks through the comparison. And for the technical harm reduction framework, how vaping compares to smoking for harm reduction covers the domain-by-domain picture.